Pharmaceutical Contract Packaging Industry Segmentation
The competitive landscape of the pharmaceutical contract packaging market is fragmented due to the presence of a large number of vendors. The major players with a significant share of the market are expanding their customer base across various regions. In addition, many companies are forming strategic and collaborative initiatives with multiple companies to increase their market share and profitability. Some of the major companies operating in the market are Ropack Inc., Sharp (UDG Healthcare), Reed-Lane Inc., and PCI Pharma Services.
- February 2024: Aptar CSP Technologies, a division of AptarGroup Inc., partnered with ProAmpac, a leader in material science and flexible packaging, to unveil the ProActive Intelligence Moisture Protect (MP-1000). This cutting-edge platform integrates Aptar CSP’s 3-Phase Activ-Polymer technology with ProAmpac’s advanced blown film technology, resulting in a moisture-adsorbing flexible packaging solution. MP-1000 marks the inaugural offering in a suite of active microclimate management packaging solutions aimed at reducing degradation risks, preserving potency, and enhancing product performance.
- June 2024: PCI Pharma Services, a leading pharmaceutical contract development and manufacturing organization (CDMO), signed a 25-year lease agreement with McGarrell Reilly. The new industrial facility will be built at the CityNorth Business Campus in Stamullen, County Meath, Ireland. Boasting direct access to the M1 motorway, this state-of-the-art development is poised to support PCI's ongoing expansion in the area.
Pharmaceutical Contract Packaging Market Leaders
-
Ropack Inc.
-
Sharp (UDG Healthcare)
-
Reed-Lane Inc.
-
PCI Pharma Services
-
UNICEP Packaging LLC
- *Disclaimer: Major Players sorted in no particular order
